-
Awarded19/09/2024
-
Today19/09/2026
Utilities
- indicates text translated automatically in your browsing language
Framework agreement for the purchase of Tibsovo® (ivosidenib)
The purpose of the framework agreement is to provide hospital pharmacies in Amgros' stakeholders with the medicinal product Tibsovo® (ivosidenib). The Capital Region of Denmark's hospital pharmacy also makes purchases with a view to reselling Greenland and the Faroe Islands.
Type: price
Description: Direkte tildeling (ingen tildelingskriterier anvendt).
Weight (percentage, exact):
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.